Through analyses of single strands of hair, researchers have shown that the dynamics of certain metal molecules are altered in ALS.| ALS News Today
When columnist Dagmar Munn's special footwear began to wear out, she went shoe shopping — which required a certain amount of resilience.| ALS News Today
Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.| ALS News Today
Electric bidets are popular among people with ALS, writes columnist Dagmar Munn, who first encountered one in Japan and is now a fan.| ALS News Today
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling patients in the U.S.| ALS News Today
Various adaptations and equipment are available that can help a person with ALS eat, dress, use the bathroom, and move around.| ALS News Today
Neither memantine nor trazodone was able to slow amyotrophic lateral sclerosis (ALS) disease progression in a platform clinical trial.| ALS News Today
An analysis in 62 ALS patients who followed the Phase 2b study's rules (protocol) found a 37.4% ALSFRS-R difference with PrimeC vs. placebo.| ALS News Today
ALS speech problems are caused by a weakening of the muscles of the mouth and throat and worsen over time as the disease progresses.| ALS News Today
Exercise has multiple benefits for people with ALS, such as preserving muscle strength and mobility, and increasing overall quality of life.| ALS News Today
Columnist Dagmar Munn explains how she moved on from a mindset of "why bother?" after her ALS diagnosis. It helps her to live well.| ALS News Today
The scientists believe the algorithm they developed could be used to help patients and doctors make better treatment and care plans.| ALS News Today
A gene therapy to increase nerve cell connectivity worked to ease motor dysfunction in an ALS mouse model but did not prolong survival.| ALS News Today
About 90% of cases of amyotrophic lateral sclerosis (ALS) are characterized as sporadic ALS, meaning they occur spontaneously.| ALS News Today
The European Commission has approved Qalsody to treat ALS patients in the EU whose disease is associated with mutations in the SOD1 gene.| ALS News Today
Inspired by the Olympic athletes at the 2024 Paris Games, columnist Dagmar Munn shares the lessons she's applying to her life with ALS.| ALS News Today
ALS is a neurodegenerative disorder marked by progressively worsening muscle weakness and neurological dysfunction.| ALS News Today
CNM-Au8 is an experimental liquid treatment for people with ALS that intends to increase cell energy.| ALS News Today
A Penn State University researcher will use the $250,000 to identify and develop neuroprotective small molecules for ALS and like diseases.| ALS News Today
The selenium elevations with Qalsody may reflect a change in the antioxidant status of nerve cells, but more research is needed.| ALS News Today
ALS is a progressive neurological disorder that damages motor neurons. Learn more about types, causes, symptoms, diagnosis, and treatment.| ALS News Today